{
    "laboratory_examinations": [
        {
            "procedure_name": "Prostate-Specific Antigen (PSA) Testing",
            "date": "Not specified",
            "findings": [
                {
                    "interval_before_evaluation": "7.5 yr",
                    "psa_level_ng_ml": 4.4,
                    "reference_range": "0.0–3.5"
                },
                {
                    "interval_before_evaluation": "7.1 yr (7 wk after first biopsy)",
                    "psa_level_ng_ml": 7.4,
                    "reference_range": "0.0–3.5"
                },
                {
                    "interval_before_evaluation": "6 yr",
                    "psa_level_ng_ml": 4.6,
                    "reference_range": "0.0–4.5"
                },
                {
                    "interval_before_evaluation": "3.25 yr",
                    "psa_level_ng_ml": 8.8,
                    "reference_range": "0.1–4.5"
                },
                {
                    "interval_before_evaluation": "2 yr",
                    "psa_level_ng_ml": 12.4,
                    "reference_range": "0.1–4.5"
                },
                {
                    "interval_before_evaluation": "18 mo",
                    "psa_level_ng_ml": 18.0,
                    "reference_range": "0.1–4.5"
                },
                {
                    "interval_before_evaluation": "9 mo",
                    "psa_level_ng_ml": 18.7,
                    "reference_range": "0.1–4.5"
                },
                {
                    "interval_before_evaluation": "3.5 mo",
                    "psa_level_ng_ml": 19.8,
                    "reference_range": "0.1–4.5"
                },
                {
                    "interval_before_evaluation": "3 mo (12 days after fifth biopsy)",
                    "psa_level_ng_ml": 20.0,
                    "reference_range": "0.1–4.5"
                },
                {
                    "interval_before_evaluation": "2 wk (after initiation of hormone treatment)",
                    "psa_level_ng_ml": 5.8,
                    "reference_range": "0.1–4.5"
                }
            ],
            "changes_over_time": "PSA levels have consistently risen over time, peaking at 20.0 ng/ml three months prior to evaluation."
        },
        {
            "procedure_name": "Blood tests including Platelet count, Blood Urea Nitrogen, and Immunoglobulins",
            "date": "Not specified",
            "findings": {
                "platelet_count": {
                    "value": 112000,
                    "reference_range": "150000 to 450000"
                },
                "blood_urea_nitrogen": {
                    "value": 26,
                    "unit": "mg/dL",
                    "reference_range": "8 to 24"
                },
                "IgM": {
                    "value": 29,
                    "unit": "mg/dL",
                    "reference_range": "50 to 200"
                },
                "other_tests": "Normal"
            },
            "changes_over_time": "Not specified."
        }
    ]
}